Employees: 03 (2023.0)Legal category: 5785Size: PMECreation date: 2012-07-15 (13 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: FREYMING-MERLEBACH (57800), Moselle
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE LES ALLIES : revenue, balance sheet and financial ratios
PHARMACIE LES ALLIES is a French company
founded 13 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in FREYMING-MERLEBACH (57800),
this company of category PME
shows in 2021 a net income positive of 214 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE LES ALLIES (SIREN 752881482)
Indicator
2021
2020
2019
2018
2017
2016
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
Net income
213 969 €
187 165 €
200 921 €
177 770 €
184 352 €
168 040 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2021, PHARMACIE LES ALLIES generates positive net income of 214 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2021: 168 k€ -> 214 k€.
Net income (2021)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
213 969 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 56%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 56%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2021)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
56.206%
Financial autonomy (2021)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
55.667%
Asset age ratio (2021)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE LES ALLIES
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
Debt ratio
253.189
186.922
139.577
101.158
76.965
56.206
Financial autonomy
25.592
31.804
38.103
45.518
50.456
55.667
Repayment capacity
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
56.212021
2019
2020
2021
Q1: 29.03
Med: 85.52
Q3: 208.44
Good-12 pts over 3 years
In 2021, the debt ratio of PHARMACIE LES ALLIES (56.21) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
55.67%2021
2019
2020
2021
Q1: 25.89%
Med: 44.41%
Q3: 64.18%
Good+8 pts over 3 years
In 2021, the financial autonomy of PHARMACIE LES ALLIES (55.7%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 92.99. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2021)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
92.989
Liquidity indicators evolution PHARMACIE LES ALLIES
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
Liquidity ratio
125.464
109.476
92.246
79.763
86.135
92.989
Interest coverage
None
None
None
None
None
None
Sector positioning
Liquidity ratio
92.992021
2019
2020
2021
Q1: 139.2
Med: 190.68
Q3: 259.62
Watch
In 2021, the liquidity ratio of PHARMACIE LES ALLIES (92.99) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.
Positioning of PHARMACIE LES ALLIES in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 220 transactions of similar company sales
in 2021,
the value of PHARMACIE LES ALLIES is estimated at
2 454 313 €
(range 1 578 135€ - 3 791 142€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2021
220 transactions
1578k€2454k€3791k€
2 454 313 €Range: 1 578 135€ - 3 791 142€
NAF 5 année 2021
Valuation method used
Net Income Multiple
213 969 €
×
11.5x
=2 454 314 €
Range: 1 578 136€ - 3 791 143€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 220 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE LES ALLIES with other companies in the same sector:
Frequently asked questions about PHARMACIE LES ALLIES
What is the revenue of PHARMACIE LES ALLIES ?
The revenue of PHARMACIE LES ALLIES is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE LES ALLIES profitable?
Yes, PHARMACIE LES ALLIES generated a net profit of 214 k€ in 2021.
Where is the headquarters of PHARMACIE LES ALLIES ?
The headquarters of PHARMACIE LES ALLIES is located in FREYMING-MERLEBACH (57800), in the department Moselle.
Where to find the tax return of PHARMACIE LES ALLIES ?
The tax return of PHARMACIE LES ALLIES is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE LES ALLIES operate?
PHARMACIE LES ALLIES operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart